Search research articles
Contact Us
Filters
Showing results (41-50 of 64) with videos related to
Page
of 7
Sort By:
Antimicrobial Agents and Chemotherapy
|
May 11, 2021
Plasma Pharmacokinetics of High-Dose Oral versus Intravenous Rifampicin in Patients with Tuberculous Meningitis: a Randomized Controlled Trial
Sean Wasserman, Angharad Davis, Cari Stek, et al.
Immunology
|
November 14, 2021
Whole blood-based measurement of SARS-CoV-2-specific T cells reveals asymptomatic infection and vaccine immunogenicity in healthy subjects and patients with solid-organ cancers
Martin J Scurr, Wioleta M Zelek, George Lippiatt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 18, 2024
Diagnostic Accuracy of Chest X-ray Computer-Aided Detection Software for Detection of Prevalent and Incident Tuberculosis in Household Contacts
Liana Macpherson, Sandra V Kik, Matteo Quartagno, et al.
Nature Communications
|
January 12, 2023
Effects of tuberculosis and/or HIV-1 infection on COVID-19 presentation and immune response in Africa
Elsa du Bruyn, Cari Stek, Remi Daroowala, et al.
Gynecologic Oncology
|
February 5, 2021
Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study
Kimberly K Leslie, Virginia L Filiaci, Adrianne R Mallen, et al.
Gynecologic Oncology
|
February 22, 2025
Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer molecularly targeted therapy consortium cohort study
Paulina J Haight, Marilyn Sanchez, Samantha M Thomas, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 27, 2025
Genomic alterations, molecularly targeted therapy, and survival: a real-world Endometrial Cancer Molecularly Targeted Therapy Consortium cohort study
Angeles Alvarez Secord, Victoria Bae-Jump, Floor Backes, et al.
American Journal of Obstetrics and Gynecology
|
May 9, 2024
Multiomic analysis of uterine leiomyomas in self-described Black and White women: molecular insights into health disparities
Nicholas W Bateman, Tamara Abulez, Christopher M Tarney, et al.
Iscience
|
January 17, 2022
Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestry
Nicholas W Bateman, Christopher M Tarney, Tamara S Abulez, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 11, 2020
Adjuvant treatment improves overall survival in women with high-intermediate risk early-stage endometrial cancer with lymphovascular space invasion
Ji Son, Laura M Chambers, Caitlin Carr, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 64) with videos related to
Sort By:
Page
of 7
Antimicrobial Agents and Chemotherapy
|
May 11, 2021
Plasma Pharmacokinetics of High-Dose Oral versus Intravenous Rifampicin in Patients with Tuberculous Meningitis: a Randomized Controlled Trial
Sean Wasserman, Angharad Davis, Cari Stek, et al.
Immunology
|
November 14, 2021
Whole blood-based measurement of SARS-CoV-2-specific T cells reveals asymptomatic infection and vaccine immunogenicity in healthy subjects and patients with solid-organ cancers
Martin J Scurr, Wioleta M Zelek, George Lippiatt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 18, 2024
Diagnostic Accuracy of Chest X-ray Computer-Aided Detection Software for Detection of Prevalent and Incident Tuberculosis in Household Contacts
Liana Macpherson, Sandra V Kik, Matteo Quartagno, et al.
Nature Communications
|
January 12, 2023
Effects of tuberculosis and/or HIV-1 infection on COVID-19 presentation and immune response in Africa
Elsa du Bruyn, Cari Stek, Remi Daroowala, et al.
Gynecologic Oncology
|
February 5, 2021
Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study
Kimberly K Leslie, Virginia L Filiaci, Adrianne R Mallen, et al.
Gynecologic Oncology
|
February 22, 2025
Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer molecularly targeted therapy consortium cohort study
Paulina J Haight, Marilyn Sanchez, Samantha M Thomas, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 27, 2025
Genomic alterations, molecularly targeted therapy, and survival: a real-world Endometrial Cancer Molecularly Targeted Therapy Consortium cohort study
Angeles Alvarez Secord, Victoria Bae-Jump, Floor Backes, et al.
American Journal of Obstetrics and Gynecology
|
May 9, 2024
Multiomic analysis of uterine leiomyomas in self-described Black and White women: molecular insights into health disparities
Nicholas W Bateman, Tamara Abulez, Christopher M Tarney, et al.
Iscience
|
January 17, 2022
Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestry
Nicholas W Bateman, Christopher M Tarney, Tamara S Abulez, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 11, 2020
Adjuvant treatment improves overall survival in women with high-intermediate risk early-stage endometrial cancer with lymphovascular space invasion
Ji Son, Laura M Chambers, Caitlin Carr, et al.
Page
of 7